MedTrace Logo

Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

NCT05143307 · Status: ENROLLING_BY_INVITATION · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2024-05-14

No results posted yet for this study

Summary

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).

Conditions

Interventions

BIOLOGICAL

EBT-101

Long term follow up of participants who received EBT-101

Sponsors & Collaborators

  • Excision BioTherapeutics

    lead INDUSTRY

Principal Investigators

  • William Kennedy, MD · Excision BioTherapeutics

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-11
Primary Completion
2037-01-31
Completion
2037-04-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05143307 on ClinicalTrials.gov